Harvard Bioscience Operating Margin 2010-2025 | HBIO

Current and historical operating margin for Harvard Bioscience (HBIO) over the last 10 years. The current operating profit margin for Harvard Bioscience as of March 31, 2025 is -2.86%.
Harvard Bioscience Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $0.09B $-0.05B -58.70%
2024-12-31 $0.10B $-0.01B -6.32%
2024-09-30 $0.10B $-0.01B -6.12%
2024-06-30 $0.10B $-0.01B -4.95%
2024-03-31 $0.11B $0.00B -1.87%
2023-12-31 $0.11B $0.00B 1.79%
2023-09-30 $0.11B $0.00B 1.79%
2023-06-30 $0.11B $0.00B -0.88%
2023-03-31 $0.11B $0.00B 1.75%
2022-12-31 $0.11B $-0.01B -6.19%
2022-09-30 $0.12B $-0.01B -4.24%
2022-06-30 $0.12B 0 0.00%
2022-03-31 $0.12B $0.00B -3.31%
2021-12-31 $0.12B $0.00B 2.52%
2021-09-30 $0.12B $0.00B 3.42%
2021-06-30 $0.11B $0.00B 2.70%
2021-03-31 $0.11B $0.00B 3.81%
2020-12-31 $0.10B $0.00B 0.98%
2020-09-30 $0.10B 0 0.00%
2020-06-30 $0.11B $0.00B -0.95%
2020-03-31 $0.11B $0.00B -1.79%
2019-12-31 $0.12B $0.00B 0.86%
2019-09-30 $0.12B $0.00B 0.84%
2019-06-30 $0.12B $0.00B 2.48%
2019-03-31 $0.12B $0.00B 2.44%
2018-12-31 $0.12B $0.00B 1.64%
2018-09-30 $0.11B 0 0.00%
2018-06-30 $0.10B $0.00B -1.00%
2018-03-31 $0.09B $0.00B -1.15%
2017-12-31 $0.08B 0 0.00%
2017-09-30 $0.08B $0.00B -1.22%
2017-06-30 $0.09B $0.00B -2.27%
2017-03-31 $0.10B $0.00B -3.16%
2016-12-31 $0.10B $0.00B -2.88%
2016-09-30 $0.11B $0.00B -1.89%
2016-06-30 $0.11B $0.00B -1.87%
2016-03-31 $0.11B $0.00B -0.91%
2015-12-31 $0.11B $0.00B -1.83%
2015-09-30 $0.11B 0 0.00%
2015-06-30 $0.11B $0.00B 1.82%
2015-03-31 $0.11B $0.00B 3.70%
2014-12-31 $0.11B $0.01B 5.56%
2014-09-30 $0.11B $0.00B 2.83%
2014-06-30 $0.11B $0.00B 1.89%
2014-03-31 $0.11B $0.00B 0.95%
2013-12-31 $0.11B $0.00B 0.95%
2013-09-30 $0.11B $0.01B 6.67%
2013-06-30 $0.11B $0.01B 6.60%
2013-03-31 $0.11B $0.01B 6.48%
2012-12-31 $0.11B $0.01B 6.36%
2012-09-30 $0.11B $0.01B 5.41%
2012-06-30 $0.11B $0.01B 5.41%
2012-03-31 $0.11B $0.01B 7.27%
2011-12-31 $0.11B $0.01B 8.33%
2011-09-30 $0.11B $0.01B 7.34%
2011-06-30 $0.11B $0.01B 9.17%
2011-03-31 $0.11B $0.01B 8.33%
2010-12-31 $0.11B $0.01B 9.26%
2010-09-30 $0.11B $0.01B 9.43%
2010-06-30 $0.10B $0.01B 9.90%
2010-03-31 $0.09B $0.01B 9.68%
2009-12-31 $0.09B $0.01B 9.30%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.020B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $6.636B 18.63
Kewaunee Scientific (KEQU) United States $0.174B 10.99